How Should Patients With Hepatic and Renal Impairment Select Anti-Infective Medications?

Infections are among the most common complications in patients with hepatic and renal impairment. However, for these special populations, anti-infective therapy is far more complex than simply choosing and taking a medication. The same antimicrobial agent that is safe and effective in healthy individuals may lead to drug accumulation, increased toxicity, and even further organ damage in patients with impaired liver or kidney function due to reduced drug metabolism and excretion.

Therefore, balancing effective infection control with hepatic and renal safety has become a critical challenge in clinical practice. With the advancement of precision medicine and clinical pharmacy, individualized medication management is increasingly emphasized in anti-infective treatment for patients with liver and kidney dysfunction. Dengyue Pharma continues to focus on the field of rational medication use in special populations and hopes to help more patients understand the importance of safe and scientific drug therapy through professional health education.

How Should Patients With Hepatic and Renal Impairment Use Anti-Infective Drugs?

Hepatic and renal impairment is a common pathological condition, and patients affected by it face additional challenges when receiving anti-infective therapy.

The liver is the primary site of drug metabolism in the body and is responsible for bile secretion, immune defense, and blood volume regulation. When liver function declines, the metabolism of certain medications may slow down, causing drugs to accumulate more easily in the body and increasing both therapeutic effects and adverse reactions.

The kidneys are the body's major excretory organs and also play endocrine and limited metabolic roles. When renal function is impaired, drugs are eliminated less efficiently, leading to accumulation and a higher risk of enhanced drug effects and adverse reactions.

Principles for Using Anti-Infective Drugs in Patients With Hepatic and Renal Impairment

1. Identify the Type of Infection

Before initiating anti-infective therapy, patients with hepatic or renal impairment should determine whether the infection is caused by bacteria, fungi, viruses, or other pathogens. This helps minimize unnecessary medication use and reduces additional stress on the liver and kidneys.

2. Consult Healthcare Professionals

Patients should proactively consult physicians or pharmacists before taking anti-infective medications. Providing detailed information about medical history, drug allergies, and liver and kidney function can help avoid inappropriate medication use.

3. Avoid Potentially Harmful Drugs

Patients with liver dysfunction should avoid medications that may cause liver injury, have significant adverse effects, or increase the risk of hepatic encephalopathy, such as:

● Chloramphenicol

● Rifampin

● Erythromycin estolate

Patients with renal impairment should avoid nephrotoxic antimicrobial agents whenever possible, including:

● Aminoglycosides

● Amphotericin B

● Polymyxins

Anti-Infective Drugs That May Be Considered in Patients With Hepatic and Renal Impairment

1. Antiviral Agents

Ribavirin

Ribavirin is a broad-spectrum antiviral medication that may be used in certain viral infections, including influenza-related complications involving hepatic and renal dysfunction. It inhibits viral replication but may cause adverse effects such as anemia and fatigue.

Acyclovir

Acyclovir is commonly used to treat herpes virus infections that may affect liver and kidney function. It selectively inhibits viral DNA polymerase and suppresses viral replication. Hematologic parameters should be monitored during treatment.

Ganciclovir

Ganciclovir may be used in patients with conditions such as macroglobulinemia complicated by herpes zoster or immunodeficiency-associated hepatic and renal failure. It reversibly inhibits viral DNA polymerase and blocks viral DNA synthesis. Fatigue and dizziness should be monitored during treatment.

Oseltamivir

Oseltamivir is indicated for influenza A and B infections in patients with impaired hepatic or renal function. By inhibiting neuraminidase activity, it prevents viral spread. Patients should be monitored for allergic reactions such as skin rashes.

2. Antibacterial Agents

Cephalosporins

Cephalosporins such as:

● Cefuroxime axetil

● Cefodizime

● Cefotaxime

may be considered in patients with renal impairment. However, dosage adjustment or cautious use is often necessary to avoid drug accumulation and toxicity. These antibiotics work by inhibiting bacterial cell wall synthesis.

Fluoroquinolones

Fluoroquinolones such as levofloxacin are widely used to treat bacterial infections, including:

● Urinary tract infections

● Respiratory tract infections

● Gastrointestinal infections

Patients should be aware of potential central nervous system side effects, including dizziness and headaches.

Aminoglycosides

Although aminoglycosides are primarily eliminated through the kidneys, patients with hepatic impairment may experience a significantly higher risk of nephrotoxicity. Therefore, these agents should be used with caution.

Macrolides

Macrolides such as:

● Erythromycin

● Azithromycin

are mainly excreted through bile. Although drug elimination may be slower in patients with liver dysfunction, they generally do not exhibit significant hepatotoxicity and may be used cautiously at standard or reduced doses as clinically appropriate.

Important Considerations During Anti-Infective Therapy

1. Regular Monitoring of Liver and Kidney Function

Patients with hepatic and renal impairment should undergo periodic monitoring of liver and kidney function during anti-infective treatment to prevent drug accumulation and toxicity.

2. Maintain Adequate Hydration

Adequate fluid intake can help facilitate drug elimination and support kidney function, unless fluid restriction is medically indicated.

3. Follow Medical Advice Strictly

All medications should be taken exactly as prescribed. Patients should not alter dosing schedules or dosages without consulting their healthcare provider.

4. Be Aware of Drug Interactions

Patients with hepatic and renal impairment often take multiple medications simultaneously. Potential drug-drug interactions should be carefully evaluated to avoid adverse reactions and unexpected toxicity.

Conclusion

Selecting anti-infective medications for patients with hepatic and renal impairment requires special caution. Patients should follow professional medical guidance, identify the underlying cause of infection, choose appropriate medications, and pay close attention to dosage adjustments and potential side effects.

Regular monitoring of liver and kidney function, along with adequate hydration and adherence to prescribed treatment plans, plays a vital role in ensuring both the effectiveness and safety of anti-infective therapy. Only through individualized medication management can optimal therapeutic outcomes be achieved while minimizing the risk of drug-related toxicity.